Encephalomyelitis, Western Equine D020241

Related MeSH Hierarchy (14)

Diseases [C] » Infections [C01] » Vector Borne Diseases » Arbovirus Infections » Encephalitis, Arbovirus » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Diseases [C] » Nervous System Diseases [C10] » Neuroinflammatory Diseases » Encephalomyelitis » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Diseases [C] » Infections [C01] » Central Nervous System Infections » Encephalomyelitis » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Diseases [C] » Infections [C01] » Central Nervous System Infections » Infectious Encephalitis » Encephalitis, Viral » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Diseases [C] » Infections [C01] » Vector Borne Diseases » Arbovirus Infections » Alphavirus Infections » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Diseases [C] » Infections [C01] » Virus Diseases » Arbovirus Infections » Encephalitis, Arbovirus » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Diseases [C] » Infections [C01] » Virus Diseases » Central Nervous System Viral Diseases » Encephalitis, Viral » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Togaviridae Infections » Alphavirus Infections » Encephalomyelitis, Equine » Encephalomyelitis, Western Equine

Description

A form of arboviral encephalitis (which primarily affects horses) endemic to western and central regions of NORTH AMERICA. The causative organism (ENCEPHALOMYELITIS VIRUS, WESTERN EQUINE) may be transferred to humans via the bite of mosquitoes (CULEX tarsalis and others). Clinical manifestations include headache and influenza-like symptoms followed by alterations in mentation, SEIZURES, and COMA. DEATH occurs in a minority of cases. Survivors may recover fully or be left with residual neurologic dysfunction, including PARKINSONISM, POSTENCEPHALITIC. (From Joynt, Clinical Neurology, 1996, Ch26, pp8-9)   MeSH

Phase 2 Indicated Drugs (1)

Phase 1 Indicated Drugs (2)


Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.